ACT TEST CATRIDGES FOR COAGUCHEK PRO SYSTEM, ACT CONTROLS FOR COAGUCHEK PRO SYSTEM

Activated Whole Blood Clotting Time

ROCHE DIAGNOSTICS CORP.

The following data is part of a premarket notification filed by Roche Diagnostics Corp. with the FDA for Act Test Catridges For Coaguchek Pro System, Act Controls For Coaguchek Pro System.

Pre-market Notification Details

Device IDK992851
510k NumberK992851
Device Name:ACT TEST CATRIDGES FOR COAGUCHEK PRO SYSTEM, ACT CONTROLS FOR COAGUCHEK PRO SYSTEM
ClassificationActivated Whole Blood Clotting Time
Applicant ROCHE DIAGNOSTICS CORP. 9115 HAGUE RD. P.O. BOX 50457 Indianapolis,  IN  46250 -0457
ContactLuann Ochs
CorrespondentLuann Ochs
ROCHE DIAGNOSTICS CORP. 9115 HAGUE RD. P.O. BOX 50457 Indianapolis,  IN  46250 -0457
Product CodeJBP  
CFR Regulation Number864.7140 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1999-08-24
Decision Date2000-01-14
Summary:summary

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.